Document Detail


Clinical trials for glaucoma neuroprotection are not impossible.
MedLine Citation:
PMID:  22249238     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: To discuss issues that affect development of new glaucoma treatments known as neuroprotection. RECENT FINDINGS: There are barriers to neuroprotection trials for glaucoma. SUMMARY: With design features discussed in the review, neuroprotection trials can be effectively carried out.
Authors:
Harry A Quigley
Related Documents :
24969068 - Oral neurovascular hamartoma: an extraordinary verdict in the oral cavity.
2488038 - Automated mammographic reporting and follow-up with an inexpensive lap-top microcomputer.
16365588 - Isolated hypoplasia of the tentorium.
6496648 - Solution intolerance among users of four chemical soft lens care regimens.
20669788 - Atypical pneumonia due to chlamydophila psittaci: 3 case reports and review of literature.
6393408 - Autoenucleation.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-13
Journal Detail:
Title:  Current opinion in ophthalmology     Volume:  -     ISSN:  1531-7021     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9011108     Medline TA:  Curr Opin Ophthalmol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Glaucoma Services and Dana Center for Preventive Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of immediate and sustained intraocular pressure rise associated with intravitreal antivas...
Next Document:  Mobile Phone Use and Incidence of Glioma in the Nordic Countries 1979-2008: Consistency Check.